Studies looking into vulnerabilities of ARID1A and BRG1 mutant cancers have proposed to target residual SWI/SNF complexes in what has been termed “cancer-selective paralog dependency” (Helming et al. 2014b; Hoffman et al. 2014). This evidence concerns the gene ARID1A and cancer.